Comparison

Gefitinib European Partner

Item no. M1749-50mg
Manufacturer AbMole
CASRN 184475-35-2
Amount 50mg
Category
Type Inhibitors
Specific against other
Purity 0,9997
Formula C22H24ClFN4O3
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias ZD-1839, Iressa
Available
Molecular Weight
446, 9
Solubility
DMSO 68 mg/mL
Bioactivity information
Gefitinib (ZD1839) is an EGFR tyrosine kinase and Akt phosphorylation inhibitor. Gefitinib significantly down-regulates CD47 expression and increases DC phagocytosis in non-small cell lung cancer cells such as PC9, H1437 and H1573. Gefitinib combined with CD47 antibody can enhance the phagocytosis of macrophages.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close